|
MEIS3P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.35999999999415E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.14460000000405E-05 |
| Normal-vs-Stage2 |
1.204160E-01 |
| Normal-vs-Stage3 |
6.334400E-01 |
| Normal-vs-Stage4 |
1.660230E-01 |
| Stage1-vs-Stage2 |
5.883400E-01 |
| Stage1-vs-Stage3 |
8.928300E-02 |
| Stage1-vs-Stage4 |
1.326500E-02 |
| Stage2-vs-Stage3 |
3.948400E-01 |
| Stage2-vs-Stage4 |
3.702200E-02 |
| Stage3-vs-Stage4 |
1.832600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59119999999713E-05 |
| Normal-vs-AfricanAmerican |
1.094240E-01 |
| Normal-vs-Asian |
8.278200E-01 |
| Caucasian-vs-AfricanAmerican |
3.396500E-02 |
| Caucasian-vs-Asian |
2.433400E-01 |
| AfricanAmerican-vs-Asian |
3.951800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.449390E-04 |
| Normal-vs-Female |
8.958500E-03 |
| Male-vs-Female |
9.817000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.010200E-01 |
| Normal-vs-Extreme_Weight |
4.121300E-03 |
| Normal-vs-Obese |
6.981400E-03 |
| Normal-vs-Extreme_Obese |
1.552610E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.125200E-01 |
| Normal_Weight-vs-Obese |
4.158400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.074800E-01 |
| Extreme_Weight-vs-Obese |
7.352400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.613600E-01 |
| Obese-vs-Extreme_Obese |
8.007200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.874400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.62863999999541E-05 |
| Normal-vs-Age(61-80Yrs) |
7.075700E-03 |
| Normal-vs-Age(81-100Yrs) |
9.054400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.308780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.914800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.396400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.610000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.617500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.467200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.42779998724541E-09 |
| Normal-VS-Type2 PRCC |
8.464400E-01 |
| Normal-VS-KIRP CIMP |
2.68180000428941E-08 |
| Normal-VS-Unclassified PRCC |
5.838700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.05830000044038E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.41628939079419E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
3.560400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.93510000023878E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
5.197000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.12720000000621E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.225600E-01 |
| Normal-vs-N1 |
7.990200E-01 |
| Normal-vs-N2 |
2.504200E-03 |
| N0-vs-N1 |
4.572400E-01 |
| N0-vs-N2 |
7.270200E-02 |
| N1-vs-N2 |
2.448200E-01 |
|
|
